The Recent Funding of Eric Lefkofsky’s Company

Recently, a very important company that is fighting the good fight against cancer was awarded a significant amount of funding. The company is called Tempus.

More About Tempus

Tempus has a mission in which they strive hard for the betterment of people’s lives when it comes to devastating cancer. Being frustrated with the fact that many medical facilities didn’t use data-enriched tools that are beneficial for patients with cancer, Tempus took upon themselves to use a data-enriched tool called genomic sequencing for cancer patients. Their mission includes redefining genomic data usage in a clinical setting. Tempus also has a goal in which every patient would benefit from the treatment of previous patients by offering them doctors with techniques to learn as they gather additional data.

The CEO and Co-founder

Eric Lefkofsky is a co-founder and CEO of Tempus. He is an American businessman who tremendously became interested in relative cancer issues especially when a loved one of his was diagnosed with cancer. Lefkofsky is originally from a suburb outside of Detroit, Michigan. His alma mater is the University of Michigan wherever earned a bachelor of art degree in 1991 in which he graduated with honors, and he earned his JD degree.

More About the Recent Round of Funding Awarded

In March of this year, Tempus gained an additional $80 million in funding that was led by T. Rowe Price. With this additional funding, Tempus can more aggressively fight the good fight against cancer. They can expand by hiring additional staff in the city of Chicago, especially in the tech and data fields. With this company just opening in 2015, they already have been hiring around 30 additional employees each month with the previous round of funding they’ve raised that amounted to $70 million. With these new endeavors from a worthwhile company that just opened a few years ago, the future is looking even more optimistic and hopeful from people suffering from cancer, their loved ones, and even more jobs for the city of Chicago.

To know more visit @: lefkofskyfoundation.com/about-eric-lefkofsky/

Working Opportunities at the CTCA

In the USA, there have been many companies rising in the biotech and health tech industries that are doing research on various diseases including cancer. Cancer Treatment Centers of America have become leading forces in that research and providers of data for businesses to analyze. The company is also an excellent career opportunity.Cancer Treatment Centers of America or CTCA has been working for almost 30 years to beat cancer. The institution believes there is not only one way to achieve that goal universally. Instead, the CTCA is dedicated to working out the right combination of personalized treatments for each of their patients.There are many teams involved in the process such s surgeons, oncologists, and many other specialists. Together, they provide advanced cancer treatment. They focus on a much safer and efficient radiation therapy, targeted drug therapies, as well as minimally invasive surgical procedures.

During the treatments, the CTCA also provides its patients with procedures to boost the immune system, to reduce pain, and to improve the overall quality of life.The Cancer Treatment Centers of America have locations across the United States. All of the facilities are fully accredited hospitals. The Cancer Treatment Centers of America have about a dozen hospital across the country. Some of the hospitals are located in Phoenix, AZ, Chicago, Il, Schaumburg, IL, Boca Raton FL, Goodyear, AZ, Zion, IL, Newman, GA, Tulsa OK, as well as Philadelphia, PA, among others. All of these locations have open positions available in several lines of work at the facilities. They have earned the Joint Commission’s Full Standards Compliance. Additionally, the CTCA had a high satisfaction rate among its patients and employees alike. On reputation sites, the CEO approval runs 81 percent.

The life/work balance that the employees can achieve has received an average score of 3.6 out of 5. The compensation and benefits are estimated by reviewers as 3.9 out of 5.The Cancer Treatment Centers of America have earned the recognition of institutions and publications. In 2016, IDG’s Computerworld put the CTCA on place number 9 on their list of Best Places to work in IT for the category of large organizations.According to the provided by employees of the CTCA, one of the most beneficial aspects of working at one of the centers is the ability to enable cancer patients to take more of a control of the disease by providing them with cutting-edge technology and personalized treatments. Employees also talk about how they get many chances to work and learn from some of the highly ranked professionals in their line of work which allows them to hone their skills, receive education and practice at the same time, and have a chance to achieve higher positions in their field.

Groupon Founder Eric Lefkofksy’s New Mission: Creating Data-Driven Cancer Treatment

Eric Lefkofksy might be known for creating Groupon, the online backbone of the best local deals. However, according to Jim Dalke’s article in ChicagoInno titled “Eric Lefkofsky’s Self-Funded Mission to Cure Cancer Through Data”, the serial entrepreneur is about to shake up medical industry.

Mr. Lefkofsky created company after an incredibly confusing and disheartening experience. His wife was diagnosed with cancer. As they went from doctor to doctor, it became clear that the data necessary for an informed decision simply wasn’t available. The treatment did not seem personalized Lefkofksy decided a change was necessary.

Mr. Lefkofsky created Tempus as a solution to this issue. By making a library consisting of previous cancer patient’s molecular compositions and an operating system that interprets it, doctors will be able to create a personalized treatment plan for their current patients. The patients have their genomes sequenced in the lab and it is then lined up with the molecular information of other cancer patients. At that point, Tempus creates a report for the doctors and provides access to the operating system to create a precise treatment plan.

Though he has great hopes for Tempus, starting a new company was not at the top of his to-do list. At this point in his career, he was not looking for all the pressure and stress that is inherent in building a successful startup. However, he has invested much of his own fortune to keep Tempus self-funded, which allows it to outpace competitors who are reliant on outside funding.

He hopes that Tempus will be one of the most successful of his businesses because of the possible impact on people’s lives. He claims that the technology could be “the most disruptive model I’ve ever seen.” Though it may take years to measure the success of the treatment options based on the data, it has the potential to save lives.

The company established partnerships with some of the healthcare industry’s biggest hitters such as the University of Chicago, the Mayo Clinic, the University of Michigan, and Northwestern University.

Eric Lefkosky has been a successful entrepreneur since 2006. He has co-founded companies in a variety of different industries like predictive analytics, marketing, venture capital, and local commerce.

He is also dedicated to a variety of philanthropic causes. He co-founded the Lefkofksy Foundation with his wife to support education, science, and more than 50 other organizations. He is also a part of The Giving Pledge.